NEW YORK, Oct 31 – Packard BioScience said Tuesday it expects to complete the sale of its Canberra Industries subsidiary, a move that would allow the company to expand its life science business.

Mike Zebarth, a spokesman for Packard BioScience, confirmed that the proceeds from the sale would be used to step up the company’s life science efforts, however, he declined to comment on whether that would be done through acquisitions or organic growth.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Dog DNA testing finds that some purebreds might not truly be purebreds, Inside Edition reports.

Mary Beckerle has returned as director of the Huntsman Cancer Institute, according to ScienceInsider.

Smithsonian Magazine reports that environmental DNA sampling can be used to track elusive organisms.

In Genome Research this week: repetitive satellite DNA in the fruit fly, transcriptome map assembly pipeline, and more.